Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
申请人:Crooks A. Peter
公开号:US20050261334A1
公开(公告)日:2005-11-24
N-n-Alkylation of nicotine converts nicotine from an agonist into an antagonist specifically for neuronal nicotinic acetylcholine receptor subtypes mediating nicotine-evoked dopamine release. Conformationally restricted analogs exhibit both high affinity and selectivity at this site, and are able to access the brain due to their ability to act as substrates for the blood-brain barrier choline transporter.
尼古丁的N-n-烷基化将尼古丁从激动剂转化为拮抗剂,特别是对于介导尼古丁诱导的多巴胺释放的神经尼古丁乙酰胆碱受体亚型。构象限制类似物在该位点表现出高亲和力和选择性,并能够进入大脑,因为它们能够作为血脑屏障胆碱转运体的底物。